Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Odonate Therapeutics Inc (ODT)

3.35   -0.17 (-4.83%) 04-14 06:32
Open: 3.45 Pre. Close: 3.52
High: 3.495 Low: 3.2619
Volume: 2,687,065 Market Cap: 129M
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer; and CONTESSA 2 and CONTESSA TRIO, which is in Phase II clinical study for central nervous system metastases and various cancer treatments. The company was founded in 2013 and is based in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.494 - 3.516 3.516 - 3.531
Low: 3.21 - 3.236 3.236 - 3.255
Close: 3.315 - 3.354 3.354 - 3.381

Technical analysis

as of: 2021-04-13 5:03:26 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.59     One year: 23.04
Support: Support1: 3.02    Support2: 2.51
Resistance: Resistance1: 13.35    Resistance2: 19.73
Pivot: 3.41
Moving Average: MA(5): 3.62     MA(20): 6.47
MA(100): 16.64     MA(250): 23.01
MACD: MACD(12,26): -3.68     Signal(9): -4.04
Stochastic oscillator: %K(14,3): 15.37     %D(3): 10.22
RSI: RSI(14): 23.98
52-week: High: 46.50  Low: 3.02  Change(%): -87.5
Average Vol(K): 3-Month: 431744  10-Days: 1850566

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ODT has closed above bottom band by 43.6%. Bollinger Bands are 88.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to ODT's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 13 Apr 2021
Should You Buy Odonate Therapeutics Inc (ODT) Stock Tuesday Morning? - InvestorsObserver

Mon, 12 Apr 2021
Is Odonate Therapeutics Inc (ODT) a Bad Choice in Biotechnology Monday? - InvestorsObserver

Fri, 09 Apr 2021
Should Biotechnology Stock Odonate Therapeutics Inc (ODT) Be in Your Portfolio Friday? - InvestorsObserver

Fri, 09 Apr 2021
Odonate Therapeutics (ODT) is Oversold: Can It Recover? - Yahoo Finance

Thu, 08 Apr 2021
Is Odonate Therapeutics (NASDAQ:ODT) In A Good Position To Invest In Growth? - Yahoo Finance

Wed, 07 Apr 2021
Is Odonate Therapeutics Inc (ODT) a Stock to Watch After Gaining 17.24% This Week? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 39
Shares Float (M) 17
% Held by Insiders 3.51
% Held by Institutions 105.79
Shares Short (K) 2,670
Shares Short P. Month (K) 3,240

Stock Financials

EPS -3.845
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.530
Profit Margin
Operating Margin
Return on Assets (ttm) -44.7
Return on Equity (ttm) -84.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -3.290
Qtrly Earnings Growth
Operating Cash Flow (M) -113
Levered Free Cash Flow (M) -67

Stock Valuations

PE Ratio -0.87
PEG Ratio
Price to Book value 0.95
Price to Sales
Price to Cash Flow -1.14

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.